Publicações científicas

CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma

Alcázar JL [ES], Miranda D, Unanue A, Novoa E, Alemán S, Madariaga L.
Department of Obstetrics and Gynecology, Clínica Universitaria de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.

Revisão:International Journal of Gynaecology and Obstetrics

Data: 1/Fev/2004

Ginecologia e Obstetrícia

Primary cytoreductive surgery is considered as one of the cornerstones in the management of patients with advanced ovarian cancer. Recently, the CA-125 serum marker has been proposed for predicting optimal cytoreduction in advanced epithelial ovarian cancer.

In this study we assessed the role of preoperative CA-125 to predict optimal cytoreduction in patients with advanced ovarian cancer. Data on patients 67 patients (mean age: 57 years old, range 21–85 years) with advanced epithelial ovarian cancer that underwent primary cytoreduction surgery at our institution were reviewed. Optimal cytoreduction was defined as the largest volume tumoral residual disease of less than 1 cm. Optimal cytoreduction was achieved in 32 patients.

CITAÇÃO DO ARTIGO  Int J Gynaecol Obstet. 2004 Feb;84(2):173-4

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra